iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.93M
Expense Ratio	0.47%
PE Ratio	n/a
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.39%
Ex-Dividend Date	Dec 17, 2024
Payout Ratio	n/a
1-Year Return	-3.05%

Volume	979
Open	25.86
Previous Close	25.83
Day's Range	25.43 - 25.86
52-Week Low	22.67
52-Week High	28.74
Beta	0.67
Holdings	79
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

41.19% of assets

Name	Symbol	Weight
Neurocrine Biosciences, Inc.	NBIX	4.41%
Scholar Rock Holding Corporation	SRRK	4.33%
argenx SE	ARGX	4.19%
Intra-Cellular Therapies, Inc.	ITCI	4.17%
SK Biopharmaceuticals Co., Ltd.	326030	4.14%
ACADIA Pharmaceuticals Inc.	ACAD	4.09%
Catalyst Pharmaceuticals, Inc.	CPRX	4.06%
Supernus Pharmaceuticals, Inc.	SUPN	3.96%
Sarepta Therapeutics, Inc.	SRPT	3.94%
Biogen Inc.	BIIB	3.91%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.101	n/a
Dec 20, 2023	$0.006	Dec 27, 2023
Jun 7, 2023	$0.008	Jun 13, 2023